Are you Dr. Robins?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 60 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
7887 Almor Dr
Verona, WI 53593Phone+1 608-263-1416- Is this information wrong?
Summary
- Dr. H Robins, MD is a hematologist in Verona, Wisconsin. He is currently licensed to practice medicine in Wisconsin, Florida, and Illinois. He is affiliated with University Hospital.
Education & Training
University of Wisconsin Hospitals and ClinicsFellowship, Medical Oncology, 1979 - 1982- University of Wisconsin Hospitals and ClinicsResidency, Internal Medicine, 1976 - 1979
Boston University School of MedicineClass of 1976
Certifications & Licensure
WI State Medical License 1977 - 2025
FL State Medical License 2021 - 2023
IL State Medical License 1988 - 1990- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Temozolomide and Radiation Therapy in Treating Patients With Brain Metastasis Secondary to Non-Small Cell Lung Cancer Start of enrollment: 2005 Dec 20
- Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer Start of enrollment: 2004 Oct 06
- A Phase II Study of Pulse Reduced Dose Rate Radiation Therapy With Bevacizumab Start of enrollment: 2012 Dec 03
Publications & Presentations
PubMed
- 1 citationsCase report: Radiographic complete response of radiation-induced glioblastoma to front-line radiotherapy: A report and molecular characterization of two unique cases.Patrick T Grogan, Jeffrey J Helgager, Dustin A Deming, Steven P Howard, Robert B Jenkins, H Ian Robins> ;Frontiers in Neurology. 2023 Jan 1
- 1 citationsGermline polymorphisms inassociated with temozolomide-related myelotoxicity risk in patients with glioblastoma treated on NRG Oncology/RTOG 0825.Michael E Scheurer, Renke Zhou, Mark R Gilbert, Melissa L Bondy, Erik P Sulman, Ying Yuan, Yanhong Liu, Elizabeth Vera, Merideth M Wendland, Emad F Youssef, Volker W S...> ;Neuro-Oncology Advances. 2022 Oct 22
- 2 citationsEntrectinib demonstrates prolonged efficacy in an adult case of radiation-refractoryfusion glioblastoma.Patrick T Grogan, Dustin A Deming, Jeffrey Helgager, Theresa Ruszkiewicz, Mustafa K Baskaya, Steven P Howard, H Ian Robins> ;Neuro-Oncology Advances. 2022 Apr 13
- Join now to see all
Grant Support
- Phase I Trial Of Intravenous Thymidine And CarboplatinNational Center For Research Resources1995
- Phase I Evaluation Of IV Melphalan And Whole Body HyperthermiaNational Center For Research Resources1995
Professional Memberships
- Member
Hospital Affiliations
University HospitalMadison, Wisconsin
